Sharbat- E- Unnab: A Review on Potent Unani Formulation
Abstract
Unani System of Medicine is also known as Greco-Arabic medicine, and developed into an elaborate scientific medical system by Arab and Persian physicians, such as Rhazes (850-925AD), Avicenna (980-1037AD), Al-Zahrawi and Ibn Nafis. It is practiced in India since eighth century AD and is a recognized Indian traditional system of medicine with good infrastructure for education; research and manufacturing unitswhich are well regulated by the Government. In Unani medicine there are well developed pharmacopeia and pharmaceutical processings for single & compound formulations for the treatment of several local and systemic ailments. The most important formulation among various Unani formulations is Sharbat-e-Unnab, a Unani pharmaceutical preparation acting as Dafa-e-Sual (antitussive), Khashunat-e-Halaq (sore throat), Musaffi-e-Khoon (blood purifier), Musakkin-e-Hiddat-e-Khoon (suppressive blood heat) etc. Unnab (Ziziphus jujuba Mill. / Jujube) fruit is the main ingredient of the formulation. Unnab is also an ingredient of Unani Joshanda which has been recommended for relief in upper respiratory tract symptoms in mild cases of COVID-19. Few scientific studies related to Sharbat Unnab have been conducted in problems like Acne vulgaris and Primary Hypertension. Apart from this Unnab, the main ingredient has also been studied for its antioxidant and anti-cancerous activities. This formulation is being used by Unani physicians since time immemorial. Therefore, this paper will describe the brief review of the formulation along with its ingredient.
Keywords: Sharbat-e-Unnab, Unani medicine, Sharbat, Unnab, Ziziphus Jujuba Mill.
Keywords:
Sharbat-e-Unnab, Unani medicine, Sharbat, Unnab, Ziziphus Jujuba Mill.DOI
https://doi.org/10.22270/jddt.v11i3-S.4836References
Anonymous. Qarabadeen-e-Majeedi. New Delhi; All India Unani Tibbi Conference: 1986, pp.197-198.
Kabeeruddin M. Bayaz kabeer Part 3. New Delhi: Idara Kitab us Shifa pp 71-77, 2010.
Anonymous. National formulary of Unani Medicine, Part -VI. Govt. of India, Ministry of Health & Family Welfare, CCRUM; 2011: 116.
Ghani N. Khazainul Advia, Vol. III: Shaikh Md Basheer& Sons, Urdu Bazar, Lahore; YNM. P. 142-144
Khan HS. Ilajul Amraz, New Delhi: CCRUM Dept of AYUSH Govt of India, 2005.
Agarwal V. Economic Plants of India, Calcutta: Kailash Parakashan, 1990; 413.
Anonymous. Guidelines for Unani Practitioners in COVID-19. Ministry of AYUSH, Govt. of India, 2020.
Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants, New Delhi: CSIR, 1956; 262.
Al-Bairuni AR. Saidana (Persian), Iraj Uftad Iran: Manuchahar Satuda, NYM, p. 932.
Prajapati ND, Pruhit SS. A Hand Book of Medicinal Plants, India: Agrobios, 2003; 553.
Khan HMA. Mohit-e-AZAM, vol. III, New Delhi: CCRUM Dept of AYUSH Ministry ofHealth & Family Welfare Govt of India, 2014; 604-606.
Masihi ASA. Kitabul Miah, vol. I, New Delhi: CCRUM Dept of AYUSH, 2014; 219.
Haleem HMA. Mufradat-e-Azeezi, New Delhi: CCRUM Dept of AYUSH, 2009; 30.
Anonymous. NFUM Part 3, New Delhi: Dept of ISM&H Ministry of Health & FamilyWelfare Govt of India, 2001; 127-128,133.
Hussain SF. Advia Mein Kam Aane Wale Paude, Lahore: Urdu Science Board 299 UpperMal Lahore, 1990; 25.
Kabeeruddin HM. Makhzanul Mufradat, New Delhi: Aijaz Publishing House, YNM, pp.403-404.
Anonymous. The Wealth of India Vol XI x-z, New Delhi: Publication & InformationDirectorate CSIR New Delhi, 1976; 111,112.
Ibn-e-Baitar, Al Jame li Mufradatil Advia Wal Aghziya, vol. 3, New Delhi: CCRUMDept of AYUSH Ministry of Health & Family Welfare Govt of India, 1999; 314-316.
Lee S, Park JG, Lee YH, Lee CG, Min BS, Kim JH, "Anti-complementary activity of triterpenoides from fruits of Zizyphus jujuba," Biological and Pharmaceutical Bulletin,2004; 27(11):1883-1886. https://doi.org/10.1248/bpb.27.1883
Matsuda H, Murakami T, Ikebata A, Yamaharaj J, and Y yoshikawa M. "Bioactivesaponins and glycosides. XIV. Structure elucidation and immunological adjuvant activity of novel proto jujubogenin type triterpene bisdesmosides, protojujubosides A, B, and B1,from the seeds of Zizyphus jujuba var. spinosa (Zizyphi Spinosi Semen)," Chemical and pharmaceutical bulletin, 1999; 47(12):1744-1748. https://doi.org/10.1248/cpb.47.1744
Mahajan R, Chopda M. "Phyto-Pharmacology of Ziziphus jujuba Mill-A plant review.,"Pharmacognosy Reviews., 2009; 3(6):320.
Esteki T, Urooj A. "Antioxidant components and activity in the peel of Ziziphus JujubaMill.," Journal of Pharmacy Research, 2012; 5(5):2705-2709.
Lee SM, Min BS, Lee CG, Kim KS, Kho YH. "Cytotoxic triterpenoids from the fruits of Zizyphus jujuba," Planta medica, 2003; 69(11):1051-1054. https://doi.org/10.1055/s-2003-45155
Mahboobus S. et. al, A Preliminary Study On The Efficacy And Safety Of Two Unani Pharmacopoeial Formulations (Itrifal Shahatra And Sharbat Unnab) In Adolescent And Young Adults Cases Of Acne Vulgaris (Busoor-Ilabaniyah): Single Armed Open Labelled Clinical Study. World Journal Of Pharmaceutical And Medical Research. 2020; 6(4):85-89.
Shahid M. Evaluation of the Efficacy of Sharbat-e-Unnab in Primary Hypertension-An open labeled randomized standard controlled study. Bangalore. National Institute of Unani Medicine; 2018 [Cited 2021 may 26]. http://localhost:8080/xmlui/handle/123456789/37630 .
Amrohvi J. Qarabadeen-e-Jalali, New Delhi: CCRUM Dept of AYUSH Ministry of Health & Family Welfare Govt of India, 2006.
Khan HMA. Qarabadeen-e-Azam, New Delhi: Aijaz Publishing House Daryaganj, 1996.
Chughtai HGM. Bayaz-e-Firozi, Lahore: Shaikh Basheer & Sons Chowk Urdu BazarLahore, 1995.
Lubhaya R. Dehlike Muntakhab Murakkabat, New Delhi: Goswami Kutub Khana Gali Qasim Jan Delhi, 1979.
Jeelani G. Kitabul Murakkabat (Makhzanul Murakkabat), New Delhi: Eajaz Publishing House, 1995.
Jurjani AAH. Zakheera Khawarzum Shahi, vol. 10, Lucknow: Matba Nami Munshi Nawal Kishor, 1903.
Arzani MA. Meezanut Tibb, Deoband: Faisal Publisher, YNM
Published
Abstract Display: 2379 
PDF Downloads: 926 PDF Downloads: 18547 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.